Purpose: The purpose of the study is to investigate the effect of neoadjuvant chemoradiation, as well as clinicopathological features, on the yield of lymph nodes and survival in rectal carcinoma. Methods: We conducted a retrospective cohort study using an institutional database. 93 patients with rectal cancer treated with curative surgery from 2009 through 2012 at a single District General Hospital in the United Kingdom were included in the study. Follow up perioed was 4 years. Patients had neoadjuvant long course chemoradiotherapy if they were stage II or III. Results: A total of 93 patients were included. 51 received neoadjuvant therapy (NEO) before resection and 42 proceeded to surgery (SURG). There was less lymph node yield in patients who received neoadjuvant therapy (21 vs. 16, p < 0.05). Examination of pathology reports revealed that all patients in the NEO group had more nodes with metastatic disease compared to the SURG group (23 vs 18, p<0.05). The sphincter preservation rate was 83% for patients operated with neoadjuvant treatment versus 95 % for those in surgery group, Patients within the neoadjuvant group had a statistically significant higher number of APR (NEO 17% vs. SURG 5% vs. p<0.01). There was no survival advantage in the neoadjuvant group. Conclusion: Preoperative CRT is associated with a reduction in the yield of lymph nodes in rectal cancer surgery. This is mainly related to radiotherapy, which exerts its effects on the lymph nodes. Also factors such as sex and the level of the tumour may affect lymph node yield.
Published in | Journal of Surgery (Volume 2, Issue 2) |
DOI | 10.11648/j.js.20140202.13 |
Page(s) | 27-31 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2014. Published by Science Publishing Group |
Lymph Nodes, Neoadjuvant Therapy, Rectal Cancer, Survival
[1] | Schmiegel W, Pox C, Adler G et al (2004) S3-Guidelines Conference ‘‘Colorectal Cancer’’ 2004. Z Gastroenterol 42:1129–1177 |
[2] | Camma C, Giunta M, Fiorica M et al (2000) Preoperative radiotherapy for resectable rectal cancer. A meta-analysis. JAMA 284:1008–1015 |
[3] | Kapiteijn E, Marijnen CA, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–646 |
[4] | Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740 |
[5] | Rosenberg R, Nekarda H, Zimmermann F et al (2008) Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival. J Surg Oncol 97:8–13 |
[6] | Sobin LH, Greene FL. (2001) TNM classification: clarification of number of regional lymph nodes for pN0. Cancer 92:452 |
[7] | Quirke P, Williams GT, Ectors N, Ensari A, Piard F, Nagtegaal I.(2007) The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol 8:651-7 |
[8] | Norwood MG, Sutton AJ, West K, Sharpe DP, Hemingway D, Kelly MJ.(2010) Lymph node retrieval in colorectal cancer resection specimens: national standards are achievable, and low numbers are associated with reduced survival. Colorectal Dis 12(4):304-9. |
[9] | Murphy J, Pocard M, Jass JR, O’Sullivan GC, Lee G, Talbot IC.(2007) Number and size of lymph nodes recovered from dukes B rectal cancers: correlation with prognosis and histologic antitumor immune response. Dis Colon Rectum 50:1526-34 |
[10] | Swanson RS, Compton CC, Stewart AK, Bland KI. (2003) The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10:65-71. |
[11] | Sermier A, Gervaz P, Egger JF, et al.(2006) Lymph node retrieval in abdominoperineal surgical specimen is radiation time-dependent [serial online]. World J Surg Oncol. 4:29. |
[12] | Wichmann MW, Muller C, Meyer G, et al. (2002) Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer. Arch Surg.137:206–210 |
[13] | Baxter NN, Morris AM, Rothenberger DA, Tepper JE. (2005) Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis. Int J Radiat Oncol Biol Phys. 61:426–431 |
[14] | Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH. (2002) Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 20:1729–1734 |
[15] | Rullier A, Laurent C, Capdepont M, et al.(2008) Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival. Am J Surg Pathol. 32:45–50 |
[16] | Tepper JE, O’Connell MJ, Niedzwiecki D, et al. (2001) Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol. 19:157–163 |
[17] | JH, Severino R, Honnebier MB, Tom P, Namiki TS. (1999) Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol. 17:2896–2900 |
[18] | Marks JH, Valsdottir EB, Rather AA, Nweze IC, Newman DA, Chernick MR. (2010) Fewer than 12 lymph nodes can be expected in a surgical specimen after high-dose chemoradiation therapy for rectal cancer. Dis Colon Rectum. 53:1023–1029 |
[19] | Canessa CE, Badia F, Fierro S, Fiol V, Hayek G.(2001) Anatomic study of the lymph nodes of the mesorectum. Dis Colon Rectum. 44:1333–1336. |
[20] | Shen SS, Haupt BX, Ro JY, Zhu J, Bailey HR, Schwartz MR. (2009) Number of lymph nodes examined and associated clinicopathologic factors in colorectal carcinoma. Arch Pathol Lab Med. 133:781–786 |
[21] | Sigurdson ER.(2003) Lymph node dissection: is it diagnostic or therapeutic? J Clin Oncol. 21:965–967 |
[22] | Thorn CC, Woodcock NP, Scott N, Verbeke C, Scott SB, Ambrose NS.(2004) What factors affect lymph node yield in surgery for rectal cancer? Colorectal Dis. 6:356–361 |
[23] | Gorog D, Nagy P, Peter A, Perner F. (2003) Influence of obesity on lymph node recovery from rectal resection specimens. Pathol Oncol Res. 9:180–183 |
[24] | Guillem JG, Diaz-Gonzalez JA, Minsky BD, et al. (2008) cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol. 26:368–373. |
[25] | Mekenkamp LJ, van Krieken JH, Marijnen CA, van de Velde CJ, Nagtegaal ID. (2009) Lymph node retrieval in rectal cancer is dependent on many factors—the role of the tumor, the patient, the surgeon, the radiotherapist, and the pathologist. Am J Surg Pathol. 33:1547–1553 |
[26] | Wang H, Safar B, Wexner SD, Denoya P, Berho M. (2009) The clinical significance of fat clearance lymph node harvest for invasive rectal adenocarcinoma following neoadjuvant therapy. Dis Colon Rectum. 52:1767–1773 |
[27] | Herrera-Ornelas L, Justiniano J, Castillo N, et al.(1987) Metastases in small lymph nodes from colon cancer. Arch Surg 122:1253–9 |
[28] | Wright FC, Law CHL, Last L, et al. (2003) Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study. Ann Surg Oncol 10(8):903–9 |
[29] | Edler D, Oehrling K, Hallstroem M, et al. (2007) The number of analyzed lymph nodes e a prognostic factor in colorectal cancer. Acta Oncol 46:975–81 |
[30] | Sermier A, Gervaz P, Egger JF, et al. (2006) Lymph node retrieval in abdominoperineal surgical specimen is radiation time-dependent. World J Surg Oncol 4:29. |
APA Style
Kolitha Goonetilleke, Rob Church, Sarah Addison, Steve Odogwu. (2014). Lymph Node Harvest in Rectal Cancer Surgery Following Neoadjuvant Chemoradiotherapy. Journal of Surgery, 2(2), 27-31. https://doi.org/10.11648/j.js.20140202.13
ACS Style
Kolitha Goonetilleke; Rob Church; Sarah Addison; Steve Odogwu. Lymph Node Harvest in Rectal Cancer Surgery Following Neoadjuvant Chemoradiotherapy. J. Surg. 2014, 2(2), 27-31. doi: 10.11648/j.js.20140202.13
@article{10.11648/j.js.20140202.13, author = {Kolitha Goonetilleke and Rob Church and Sarah Addison and Steve Odogwu}, title = {Lymph Node Harvest in Rectal Cancer Surgery Following Neoadjuvant Chemoradiotherapy}, journal = {Journal of Surgery}, volume = {2}, number = {2}, pages = {27-31}, doi = {10.11648/j.js.20140202.13}, url = {https://doi.org/10.11648/j.js.20140202.13}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.js.20140202.13}, abstract = {Purpose: The purpose of the study is to investigate the effect of neoadjuvant chemoradiation, as well as clinicopathological features, on the yield of lymph nodes and survival in rectal carcinoma. Methods: We conducted a retrospective cohort study using an institutional database. 93 patients with rectal cancer treated with curative surgery from 2009 through 2012 at a single District General Hospital in the United Kingdom were included in the study. Follow up perioed was 4 years. Patients had neoadjuvant long course chemoradiotherapy if they were stage II or III. Results: A total of 93 patients were included. 51 received neoadjuvant therapy (NEO) before resection and 42 proceeded to surgery (SURG). There was less lymph node yield in patients who received neoadjuvant therapy (21 vs. 16, p < 0.05). Examination of pathology reports revealed that all patients in the NEO group had more nodes with metastatic disease compared to the SURG group (23 vs 18, p<0.05). The sphincter preservation rate was 83% for patients operated with neoadjuvant treatment versus 95 % for those in surgery group, Patients within the neoadjuvant group had a statistically significant higher number of APR (NEO 17% vs. SURG 5% vs. p<0.01). There was no survival advantage in the neoadjuvant group. Conclusion: Preoperative CRT is associated with a reduction in the yield of lymph nodes in rectal cancer surgery. This is mainly related to radiotherapy, which exerts its effects on the lymph nodes. Also factors such as sex and the level of the tumour may affect lymph node yield.}, year = {2014} }
TY - JOUR T1 - Lymph Node Harvest in Rectal Cancer Surgery Following Neoadjuvant Chemoradiotherapy AU - Kolitha Goonetilleke AU - Rob Church AU - Sarah Addison AU - Steve Odogwu Y1 - 2014/04/10 PY - 2014 N1 - https://doi.org/10.11648/j.js.20140202.13 DO - 10.11648/j.js.20140202.13 T2 - Journal of Surgery JF - Journal of Surgery JO - Journal of Surgery SP - 27 EP - 31 PB - Science Publishing Group SN - 2330-0930 UR - https://doi.org/10.11648/j.js.20140202.13 AB - Purpose: The purpose of the study is to investigate the effect of neoadjuvant chemoradiation, as well as clinicopathological features, on the yield of lymph nodes and survival in rectal carcinoma. Methods: We conducted a retrospective cohort study using an institutional database. 93 patients with rectal cancer treated with curative surgery from 2009 through 2012 at a single District General Hospital in the United Kingdom were included in the study. Follow up perioed was 4 years. Patients had neoadjuvant long course chemoradiotherapy if they were stage II or III. Results: A total of 93 patients were included. 51 received neoadjuvant therapy (NEO) before resection and 42 proceeded to surgery (SURG). There was less lymph node yield in patients who received neoadjuvant therapy (21 vs. 16, p < 0.05). Examination of pathology reports revealed that all patients in the NEO group had more nodes with metastatic disease compared to the SURG group (23 vs 18, p<0.05). The sphincter preservation rate was 83% for patients operated with neoadjuvant treatment versus 95 % for those in surgery group, Patients within the neoadjuvant group had a statistically significant higher number of APR (NEO 17% vs. SURG 5% vs. p<0.01). There was no survival advantage in the neoadjuvant group. Conclusion: Preoperative CRT is associated with a reduction in the yield of lymph nodes in rectal cancer surgery. This is mainly related to radiotherapy, which exerts its effects on the lymph nodes. Also factors such as sex and the level of the tumour may affect lymph node yield. VL - 2 IS - 2 ER -